Home Page
About Us
Editorial Board
Instructions to Authors
Contact Us
Archive
Author Index
Web Site of Urooncology Association
Archive
Author Index
Web Site of Urooncology Association
E-ISSN:2667-4610
Toggle navigation
Home Page
About Us
Editorial Board
Instructions to Authors
Contact Us
Editorial
Defining the ideal patient for active surveillance in localized prostate cancer and the impact of active surveillance studies on clinical practice
Ayhan Dirim
Hakan Özkardeş
Bull Urooncol 2011; 10: 41-46
Full
Text
Read
PDF
Review
The developments in paradigm of prostate cancer in recent years
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Bull Urooncol 2014; 13: 1-7
Full
Text
Read
PDF
PSA: past, today and tomorrow
Levent Mert Günay
Sertaç Yazıcı
Haluk Özen
Bull Urooncol 2011; 10: 5-10
Full
Text
Read
PDF
An update on palliative therapy in advanced prostate cancer
Kaan Özdedeli
Uğur Kuyumcuoğlu
Bull Urooncol 2014; 13: 8-14
Full
Text
Read
PDF
Current analysis of urinary biomarkers for prostate cancer
Faruk Yencilek
Hakan Koyuncu
Bull Urooncol 2011; 10: 11-16
Full
Text
Read
PDF
Prostate cancer, screening and diagnosis according to EAU and AUA 2013 updates and practical considerations
Tünkut Doğanca
Can Öbek
Bull Urooncol 2014; 13: 15-20
Full
Text
Read
PDF
Can prostate cancer be prevented?
İlkan Yüksel
Mustafa Kaplan
Bull Urooncol 2011; 10: 17-21
Full
Text
Read
PDF
The role of surgery for high-risk prostate cancer
Oktay Üçer
Talha Müezzinoğlu
Bull Urooncol 2014; 13: 21-24
Full
Text
Read
PDF
Does inhibition of inflammation help in preventing prostate cancer ?
Ali İhsan Arık
Ahmet Güdeloğlu
Cemil Uygur
Bull Urooncol 2011; 10: 22-26
Full
Text
Read
PDF
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
Dr. Ece Konaç
Dr. Sinan Sözen
Bull Urooncol 2017; 16: 22-27
DOI: 10.4274/uob.606
Full
Text
Read
PDF
Lympadenectomy in prostate cancer
Murat Koşan
Bull Urooncol 2014; 13: 25-28
Full
Text
Read
PDF
The effect of trace elements in prostate cancer
İlker Çelen
Feriye Şenol
Talha Müezzinoğlu
Bull Urooncol 2011; 10: 27-32
Full
Text
Read
PDF
Comparing outcomes of external radiotherapy modalities for prostate cancer
Şefik İğdem
Bull Urooncol 2014; 13: 29-32
Full
Text
Read
PDF
Has DNA methylation any impact in prostate cancer diagnosis?
Buket Kosova
Rukiye Özel
Çağdaş Aktan
Bull Urooncol 2011; 10: 33-40
Full
Text
Read
PDF
In which fields intermittent androgen deprivation therapy can be used in 2014?
Yasin Ceylan
Bu¨lent Gu¨nlu¨soy
Bull Urooncol 2014; 13: 33-36
Full
Text
Read
PDF
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
Tayyar Alp Özkan
Özdal Dillioğlugil
Bull Urooncol 2014; 13: 41-45
Full
Text
Read
PDF
A critical analysis of surgical curative treatments options in localised prostate cancer: open, laparoscopic, and robotassisted radical prostatectomy
Ender Özden
Yakup Bostancı
Yarkın Kamil Yakupoğlu
Bull Urooncol 2011; 10: 47-50
Full
Text
Read
PDF
The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer
Bülent Öztürk
Tufan Çiçek
Bull Urooncol 2014; 13: 50-53
Full
Text
Read
PDF
Algorithmic approach to rising PSA after curative prostate cancer treatment
Levent Mert Günay
Şevket Tolga Tombul
Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
Full
Text
Read
PDF
The influence of age on localized prostate cancer: Surgical result of patients over 70 years
Erdal Benli
Ali Ayyıldız
Bull Urooncol 2014; 13: 54-57
Full
Text
Read
PDF
Could focal therapy in prostate cancer replace standard therapy in the future?
Saadettin Y. Eskiçorapçı
Cihan Toktaş
Bull Urooncol 2011; 10: 56-62
Full
Text
Read
PDF
Outstanding variations in the treatment of prostate cancer bone metastases
İbrahim Cüreklibatır
Bull Urooncol 2014; 13: 58-62
Full
Text
Read
PDF
Neoadjuvant and adjuvant treatment modalities for prostate cancer
Erkan Erkan
Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
Full
Text
Read
PDF
How affected Active Surveillance the quality of life in low-risk localized prostate cancer?
İlker Çelen
Sinharib Çitgez
Talha Müezzinoğlu
Bull Urooncol 2014; 13: 63-66
Full
Text
Read
PDF
The importance of cellular androgenic hormonal mechanisms in treatment and progression of prostate cancer
Bertrand Tombal
Bull Urooncol 2013; 12: 65-70
Full
Text
Read
PDF
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
İlker Tinay
Levent Türkeri
Bull Urooncol 2016; 15: 65-68
DOI: 10.4274/uob.434
Full
Text
Read
PDF
Sentinel Lymph Node Biopsy in Lymphadenectomy for Prostate Cancer
Cenk Acar
Henk van der Poel
Bull Urooncol 2016; 15: 69-75
DOI: 10.4274/uob.625
Full
Text
Read
PDF
What is the evidence-based ideal treatment of clinical locally advanced (cT3) prostate cancer?
Asıf Yıldırım
Erem Kaan Başok
Bull Urooncol 2011; 10: 70-75
Full
Text
Read
PDF
Is prostate cancer be screened according to Turkey data?
Rahmi Gökhan Ekin
Ferruh Zorlu
Bull Urooncol 2013; 12: 71-75
Full
Text
Read
PDF
Active surveillance in low risk prostate cancer
Ozan Bozkurt
Ömer Demir
Bull Urooncol 2013; 12: 76-79
Full
Text
Read
PDF
Hormonal treatment of metastatic prostate cancer: Today and future
Hasan Soydan
Kadir Baykal
Bull Urooncol 2011; 10: 76-81
Full
Text
Read
PDF
Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy
Ömer Burak Argun
Can Öbek
Ali Rıza Kural
Bull Urooncol 2016; 15: 76-79
DOI: 10.4274/uob.635
Full
Text
Read
PDF
Treatment options in low-intermediate risk prostate cancer
Saadettin Yılmaz Eskiçorapçı
Deniz Bolat
Bull Urooncol 2013; 12: 80-85
Full
Text
Read
PDF
Immunotherapy in prostate cancer
Murat Lekili
Bull Urooncol 2011; 10: 82-84
Full
Text
Read
PDF
Nomograms for prostate cancer: which and when to use
Saadettin Eskiçorapçı
Deniz Bolat
Bull Urooncol 2012; 11: 85-91
Full
Text
Read
PDF
Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
Yaşar Bedük
Bull Urooncol 2011; 10: 85-89
Full
Text
Read
PDF
Radiotherapy in low and intermediate-risk prostate cancer
Deniz Yalman
Bull Urooncol 2013; 12: 86-91
Full
Text
Read
PDF
Recommendations of Diet and Lifestyle in Prostate Cancer Patients
Serdar Çelik
Bull Urooncol 2015; 14: 88-93
DOI: 10.4274/uob.307
Full
Text
Read
PDF
What is the best cutoff value of PSA in detection of prostate cancer
Hakan Gemalmaz
Bull Urooncol 2012; 11: 92-95
Full
Text
Read
PDF
What is the Approach to Negative Prostate Biopsies?
Bora İrer
Güven Aslan
Bull Urooncol 2015; 14: 94-96
DOI: 10.4274/uob.310
Full
Text
Read
PDF
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
Hayrettin Şahin
Mehmet Çetinkaya
Hasan Deliktaş
Bull Urooncol 2017; 16: 95-100
DOI: 10.4274/uob.620
Full
Text
Read
PDF
NON-PSA biomarkers for prostate cancer
Yarkın Kamil Yakupoğlu
Yakup Bostancı
Ender Özden
Bull Urooncol 2012; 11: 96-102
Full
Text
Read
PDF
Surgical treatment and/or radiotherapy in high risk prostate cancer
Fatih Bıçaklıoğlu
Cenk Acar
Sinan Sözen
Bull Urooncol 2013; 12: 97-101
Full
Text
Read
PDF
Intermittent Versus Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer: Review
Mehmet Yıldızhan
Mehmet Dündar
Mehmet Şirin Ertek
Bull Urooncol 2015; 14: 97-101
DOI: 10.4274/uob.315
Full
Text
Read
PDF
Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer
Enis Kervancıoğlu
Murat Koşan
Bull Urooncol 2015; 14: 102-107
DOI: 10.4274/uob.320
Full
Text
Read
PDF
Repeat prostate biopsy: who, when, how?
Hayrettin Şahin
Bull Urooncol 2012; 11: 103-107
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
Yavuz Selim Süral
Çağ Çal
Bull Urooncol 2013; 12: 106-110
Full
Text
Read
PDF
Focal Therapy for Prostate Cancer: Current Status of HIFU
Tayyar Alp Özkan
Saadettin Eskiçorapçı
Bull Urooncol 2015; 14: 108-112
DOI: 10.4274/uob.321
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
Bülent Akdoğan
Bull Urooncol 2013; 12: 111-114
Full
Text
Read
PDF
Radical Prostatectomy and Lymphadenectomy in the High-Risk Prostate Cancer: Surgical Technique, Functional and Oncologic Outcomes
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2015; 14: 113-119
DOI: 10.4274/uob.324
Full
Text
Read
PDF
Active surveillance for localized prostate cancer
İlker Tınay
Levent Türkeri
Bull Urooncol 2012; 11: 114-118
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
Gürbüz Görümlü
Erdem Göker
Bull Urooncol 2013; 12: 115-117
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: denosumab, alpharadin
Hakan Gemalmaz
Bull Urooncol 2013; 12: 118-122
Full
Text
Read
PDF
Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy
Ali Cansu Bozacı
Bülent Akdoğan
Haluk Özen
Bull Urooncol 2012; 11: 119-123
Full
Text
Read
PDF
Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
Mehmet Yıldızhan
Hakan Gemalmaz
Mehmet Şirin Ertek
Bull Urooncol 2015; 14: 120-127
DOI: 10.4274/uob.328
Full
Text
Read
PDF
Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer
İlker Çelen
Yasin Ceylan
Bull Urooncol 2013; 12: 123-126
Full
Text
Read
PDF
Current surgical approaches in local invasive prostate cancer: urologist approach
Zafer Kozacıoğlu
Bülent Günlüsoy
Bull Urooncol 2012; 11: 124-128
Full
Text
Read
PDF
How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?
İlker Çelen
Murat Lekili
Bull Urooncol 2013; 12: 127-131
Full
Text
Read
PDF
Active Surveillance in Prostate Cancer
Volkan İzol
Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132
DOI: 10.4274/uob.820
Full
Text
Read
PDF
Prostate Biopsy 2014: TRUS, MRI/TRUS Fusion? Transrectal? Transperineal?
Kaan Çömez
Ozan Bozkurt
Mehmet Uğur Mungan
Bull Urooncol 2015; 14: 128-135
DOI: 10.4274/uob.329
Full
Text
Read
PDF
Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective
Ömür Karakoyun Çelik
Bull Urooncol 2012; 11: 129-133
Full
Text
Read
PDF
Radical prostatectomy indications and outcomes in the high-risk localised prostate cancer
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2013; 12: 132-136
Full
Text
Read
PDF
Management of recurrences after radiation therapy used for curative intent in prostate cancer
Yılören Tanıdır
Levent Türkeri
Bull Urooncol 2012; 11: 134-141
Full
Text
Read
PDF
Multiparametric MR in Prostate Cancer: General Practical Application Advices
Seçil Mustafa
Basara Işıl
Altay Canan
Bull Urooncol 2015; 14: 136-143
DOI: 10.4274/uob.330
Full
Text
Read
PDF
Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy
Ali Cansu Bozacı
Sertaç Yazıcı
Bull Urooncol 2013; 12: 137-141
Full
Text
Read
PDF
AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?
Deniz Yalman
Bull Urooncol 2015; 14: 144-149
DOI: 10.4274/uob.339
Full
Text
Read
PDF
Prostate cancer in the era of robotic surgery
Çag Çal
Bull Urooncol 2012; 11: 150-155
Full
Text
Read
PDF
‘Nanotechnology Applications’ in the Treatment of Prostate Cancer
Ali Furkan Batur
Kerem Gencer Kutman
Mustafa Suat Bolat
Bull Urooncol 2015; 14: 150-155
DOI: 10.4274/uob.375
Full
Text
Read
PDF
Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T
Güven Aslan
Bull Urooncol 2012; 11: 156-158
Full
Text
Read
PDF
Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”
Ender Özden
Mehmet Necmettin Mercimek
Bull Urooncol 2015; 14: 156-160
DOI: 10.4274/uob.379
Full
Text
Read
PDF
New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100
Sıtkı Ün
Ferruh Zorlu
Bull Urooncol 2012; 11: 159-163
Full
Text
Read
PDF
Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy
Levent Kabasakal
Bull Urooncol 2016; 15: 159-162
DOI: 10.4274/uob.616
Full
Text
Read
PDF
Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?
Gül Alço
Sefik İğdem
Bull Urooncol 2015; 14: 161-164
DOI: 10.4274/uob.387
Full
Text
Read
PDF
Active Surveillance in Prostate Cancer: Can We Expand the Indications?
Hacı Murat Akgül
Asgar Garayev
İlker Tinay
Bull Urooncol 2016; 15: 163-166
DOI: 10.4274/uob.619
Full
Text
Read
PDF
Update in the management of skeletal related events for metastatic prostate cancer: Denosumab, Alfaradin
Serdar Çelik
Uğur Mungan
Bull Urooncol 2012; 11: 164-167
Full
Text
Read
PDF
The significance of tertiary Gleason pattern in prostate cancer
H. Hüseyin Tavukçu
Polat Türker
Bull Urooncol 2012; 11: 168-172
Full
Text
Read
PDF
Nursing interventions in patients receiving Taxan Chemotherapy
Yeter Kırdal
Bull Urooncol 2012; 11: 173-177
Full
Text
Read
PDF
Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients
İbrahim Kulaç
Bull Urooncol 2014; 13: 196-200
DOI: 10.4274/uob.159
Full
Text
Read
PDF
Molecular Biology in Diagnosis and Treatment of Prostate Cancer
Ece Konaç
Sinan Sözen
Bull Urooncol 2014; 13: 228-235
DOI: 10.4274/uob.194
Full
Text
Read
PDF
Current Situation in the Use of 5-Alpha Reductase Inhibitors for Prostatic Diseases
Murat Koşan
Bull Urooncol 2014; 13: 244-246
DOI: 10.4274/uob.212
Full
Text
Read
PDF
The Effects of Hormonal Therapy on Quality of Life in Prostate Cancer
Yusuf Şenoğlu
Kamil Çam
Bull Urooncol 2015; 14: 317-320
DOI: 10.4274/uob.463
Full
Text
Read
PDF
Article - Comment
Pathological characteristics of prostate cancer detected through prostate specific antigen based screening
Sinan Ekici
Bull Urooncol 2006; 5: 27-29
Full
Text
Read
PDF
Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance
Kadir Baykal
Cüneyt Adayener
Bull Urooncol 2006; 5: 27-28
Full
Text
Read
PDF
Time to prostate spesific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
Mustafa Kaplan
Bull Urooncol 2006; 5: 28-30
Full
Text
Read
PDF
Under diagnosis and over diagnosis of prostate cancer
Mustafa Kaplan
Bull Urooncol 2007; 6: 29-33
Full
Text
Read
PDF
Finasterid improves the sensitivity of digital rectal examination for prostate cancer detection
Ahmet Soylu
Bull Urooncol 2007; 6: 29-31
Full
Text
Read
PDF
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy—a propensity scoring approach
Cemil Uygur
Bull Urooncol 2007; 6: 32-33
Full
Text
Read
PDF
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
Kadir Baykal
Hasan Soydan
Bull Urooncol 2007; 6: 33-35
Full
Text
Read
PDF
Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer
Recep Büyükalpelli
Bull Urooncol 2007; 6: 36-40
Full
Text
Read
PDF
Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer
Ahmet Tunçkiran
Murat Bozlu
Bull Urooncol 2007; 6: 36-38
Full
Text
Read
PDF
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
Kadir Türkölmez
Bull Urooncol 2008; 7: 41-43
Full
Text
Read
PDF
Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
Oğuz Acar
Bull Urooncol 2009; 8: 47-51
Full
Text
Read
PDF
Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer
Ali F. Şahin
Bull Urooncol 2012; 11: 178-180
Full
Text
Read
PDF
Bph
Statin's role on protection from the benign prostatic hyperplasia and prostate cancer
Eray Hasırcı
A. İbrahim Oğuzülgen
Bull Urooncol 2012; 11: 270-274
Full
Text
Read
PDF
Pathology
Prostate cancer: New developments in pathogenesis and prognostic repercussions
Bora Gürel
Bull Urooncol 2013; 12: 279-284
Full
Text
Read
PDF
1
2
3
4
»
Advanced Search
About Journal
Forms
Useful Links
Subscribe
×
×
Subscribe
Full Name
E-mail